Sort
48,018 grants matching “immunotherapy”
Adaptive-Innate Immune Crosstalk in TGF-B Control of Peripheral T Cell Tolerance
$524,247Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2019 · AI
Adaptive-Innate Immune Crosstalk in TGF-B Control of Peripheral T Cell Tolerance
$524,247Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2018 · AI
Adaptive-Innate Immune Crosstalk in TGF-B Control of Peripheral T Cell Tolerance
$524,247Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2017 · AI
Regulatory T cells in Autoimmune Disease
$524,244Charles Garrison Fathman · Brigham And Women'S Hospital · U19 · FY2007 · AI
Boosting anti-HIV immunity through manipulation of Tfh function.
$524,241Elias K Haddad · Vgti Florida · R01 · FY2013 · AI
Induced tolerogenic dendritic cell therapy of allergic diseases
$524,143Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2011 · AI
UCSF Project 1
$524,054Trever G Bivona · University Of California, San Francisco · U54 · FY2021 · CA
Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer
$524,053Tuan Vo-Dinh · Duke University · R01 · FY2021 · EB
GMP Biologics
$524,000Victor M Lemas · Johns Hopkins University · P30 · FY2020 · CA
Immune Regulation of Neuronal Injury and Repair
$524,000Kathryn Jane Jones · Indiana University Indianapolis · R01 · FY2015 · NS
GMP Biologics
$524,000Victor M Lemas · Johns Hopkins University · P30 · FY2021 · CA
GMP Biologics
$524,000Victor M Lemas · Johns Hopkins University · P30 · FY2019 · CA
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
$523,990Vanessa Bellat · Weill Medical Coll Of Cornell Univ · R37 · FY2025 · CA
Caspases in Inflammatory Cell Death Networks
$523,976Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · GM
Caspases in Inflammatory Cell Death Networks
$523,976Guy S Salvesen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · GM
Novel CART Cells for Treating AML
$523,923Xianxin Hua · University Of Pennsylvania · R01 · FY2022 · CA
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$523,886Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
IL-1 HOMOLOGUES PROMOTE THE ACUTE INFLAMMATORY RESPONSE TO MELANOMA
$523,876Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
GMP Biologics
$523,867Victor M Lemas · Johns Hopkins University · P30 · FY2018 · CA
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
$523,841Diane M Simeone · University Of California, San Diego · R01 · FY2024 · CA
Development of a RUVBL1/2 Inhibitor as a Radiosensitizer and Immune Stimulator for NSCLC
$523,830Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2024 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$523,816Manish Bais · Boston University Medical Campus · R01 · FY2024 · DE
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
$523,812Cloud Peter Paweletz · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC
$523,661Xiao-Jing Wang · University Of California At Davis · R01 · FY2023 · DE
The role of plasmacytoid dendritic cells in corneal immunity
$523,632Pedram Hamrah · Tufts Medical Center · R01 · FY2017 · EY